1.
A web-based app to provide personalized recommendations for COVID-19
by Thieme, Alexander H
Nature medicine, 2022-06-01, Vol.28 (6), p.1105-1106
2.
Author Correction: Modeling COVID-19 scenarios for the United States
by Reiner, Robert C., Jr
Nature medicine, 2020-12-01, Vol.26 (12), p.1950-1950
3.
Author Correction: A dynamic COVID-19 immune signature includes associations with poor prognosis
by Laing, Adam G
Nature medicine, 2020-12, Vol.26 (12), p.1951-1951
4.
Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection
by Feng, Shuo
Nature medicine, 2021-11, Vol.27 (11), p.2032-2040
5.
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study
by Monin, Leticia
The lancet oncology, 2021-06, Vol.22 (6), p.765-778
6.
A global survey of potential acceptance of a COVID-19 vaccine
by Lazarus, Jeffrey V
Nature medicine, 2021-02, Vol.27 (2), p.225-228
7.
Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters
by Tostanoski, Lisa H
Nature medicine, 2020-11, Vol.26 (11), p.1694-1700
8.
Looking beyond COVID-19 vaccine phase 3 trials
by Kim, Jerome H
Nature medicine, 2021-02, Vol.27 (2), p.205-211
9.
Individual preferences for COVID-19 vaccination in China
by Leng, Anli
Vaccine, 2021-01-08, Vol.39 (2), p.247-254
10.
Resolution of coronavirus disease 2019 (COVID-19)
by Habas, Khaled
Expert review of anti-infective therapy, 2020-12-01, Vol.18 (12), p.1201-1211
11.
COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries
by Solís Arce, Julio S
Nature medicine, 2021, Vol.27 (8), p.1385-1394
12.
"The Covid-19 crisis has held up a mirror to healthcare systems worldwide"
by Matthew Taylor
RSA journal, 2020-01-01 (2), p.2
13.
Immune determinants of COVID-19 disease presentation and severity
by Brodin, Petter
Nature medicine, 2021-01, Vol.27 (1), p.28-33
14.
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
by Khoury, David S
Nature medicine, 2021-07, Vol.27 (7), p.1205-1211
16.
New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates
by Ura, Takehiro
Vaccine, 2021-01-08, Vol.39 (2), p.197-201
17.
Broad cross-national public support for accelerated COVID-19 vaccine trial designs
by Broockman, David
Vaccine, 2021-01-08, Vol.39 (2), p.309-316
18.
NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge
by Guebre-Xabier, Mimi
Vaccine, 2020-11-25, Vol.38 (50), p.7892-7896
19.
Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysis
by Choi, Angela
Nature medicine, 2021-11, Vol.27 (11), p.2025-2031
20.
Seasonal coronavirus protective immunity is short-lasting
by Eidge, Arthur W. D
Nature medicine, 2020-11, Vol.26 (11), p.1691-1693
